Zhenfa Zhang

2.2k total citations · 1 hit paper
90 papers, 1.2k citations indexed

About

Zhenfa Zhang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Zhenfa Zhang has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Zhenfa Zhang's work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Diagnosis and Treatment (26 papers) and Ferroptosis and cancer prognosis (14 papers). Zhenfa Zhang is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Diagnosis and Treatment (26 papers) and Ferroptosis and cancer prognosis (14 papers). Zhenfa Zhang collaborates with scholars based in China, United States and France. Zhenfa Zhang's co-authors include Dongsheng Yue, Changli Wang, Lianmin Zhang, Chenguang Li, Chen Chen, Mengzhe Zhang, Leina Sun, Jian You, Bingsheng Sun and Yanan Cui and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zhenfa Zhang

83 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma

2025 33 citations Zhenfa Zhang, Dingli Wang et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenfa Zhang China	20	464	461	411	319	158	90	1.2k
David James VanderWeele United States	15	355 0.8×	485 1.1×	300 0.7×	262 0.8×	108 0.7×	57	1.0k
Zhenhua Zhai China	14	251 0.5×	685 1.5×	484 1.2×	356 1.1×	138 0.9×	22	1.4k
Qingfang Li China	17	222 0.5×	437 0.9×	336 0.8×	235 0.7×	175 1.1×	37	1.0k
Yiyi Yu China	21	460 1.0×	447 1.0×	741 1.8×	327 1.0×	100 0.6×	99	1.4k
Prabhjot Kaur United States	18	450 1.0×	629 1.4×	353 0.9×	332 1.0×	139 0.9×	45	1.3k
Martina Kluth Germany	22	644 1.4×	768 1.7×	327 0.8×	415 1.3×	84 0.5×	75	1.3k
Derya Duranyıldız Türkiye	22	234 0.5×	603 1.3×	662 1.6×	294 0.9×	282 1.8×	85	1.4k
Puay Hoon Tan Singapore	18	461 1.0×	597 1.3×	484 1.2×	361 1.1×	249 1.6×	41	1.4k
Alexios Matikas Sweden	19	370 0.8×	395 0.9×	929 2.3×	413 1.3×	276 1.7×	92	1.4k

Countries citing papers authored by Zhenfa Zhang

Since Specialization

Citations

This map shows the geographic impact of Zhenfa Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenfa Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenfa Zhang more than expected).

Fields of papers citing papers by Zhenfa Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenfa Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenfa Zhang. The network helps show where Zhenfa Zhang may publish in the future.

Co-authorship network of co-authors of Zhenfa Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenfa Zhang. A scholar is included among the top collaborators of Zhenfa Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenfa Zhang. Zhenfa Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Zhenfa, Dingli Wang, Shuai Jiang, et al.. (2025). Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. Journal for ImmunoTherapy of Cancer. 13(2). e010787–e010787. 33 indexed citations breakdown →

Zhang, Pengpeng, et al.. (2024). Purine metabolism in lung adenocarcinoma: A single‐cell analysis revealing prognostic and immunotherapeutic insights. Journal of Cellular and Molecular Medicine. 28(8). e18284–e18284. 18 indexed citations

Zhang, Lianmin, Yanan Cui, Jie Mei, Zhenfa Zhang, & Pengpeng Zhang. (2024). Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies. Cell Proliferation. 57(11). e13703–e13703. 29 indexed citations

Zhang, Pengpeng, Zijun Yang, Liu Zuo, et al.. (2024). Deciphering lung adenocarcinoma evolution: Integrative single‐cell genomics identifies the prognostic lung progression associated signature. Journal of Cellular and Molecular Medicine. 28(11). e18408–e18408. 17 indexed citations

Zhang, Mengzhe, Yue Li, Pengpeng Zhang, et al.. (2024). Exploring clinical factors to predict the survival of patients with resectable non-small cell lung cancer with neoadjuvant immunotherapy. European Journal of Cardio-Thoracic Surgery. 66(4). 1 indexed citations

Zhang, Pengpeng, et al.. (2024). Integrating machine learning and single‐cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers. Journal of Cellular and Molecular Medicine. 28(13). e18516–e18516. 11 indexed citations

Jia, Bin, et al.. (2024). Subxiphoid video–assisted thoracoscopic extend thymectomy with sternal suspension for thymoma. Thoracic Cancer. 15(30). 2185–2192. 1 indexed citations

Zhang, Mengzhe, et al.. (2024). Integrated analysis highlights the significance role of ITGAL in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 28(8). e18289–e18289. 3 indexed citations

Zhang, Qiang, Yu Zhang, Leina Sun, et al.. (2024). Injectable hydrogel with doxorubicin-loaded ZIF-8 nanoparticles for tumor postoperative treatments and wound repair. Scientific Reports. 14(1). 9983–9983. 25 indexed citations

10.

Huang, Wei, Fengping Liu, Gang Xiang, et al.. (2023). 3D C–Co–N-anchored MWCNTs derived from metal–organic frameworks as high-performance electrochemical sensing platforms for the sensitive detection of adrenaline. The Analyst. 148(15). 3524–3530. 5 indexed citations

11.

Wang, Hao, Wenxu Liu, Dan Wang, et al.. (2023). Noncoding SNP at rs1663689 represses ADGRG6 via interchromosomal interaction and reduces lung cancer progression. EMBO Reports. 24(7). e56212–e56212. 6 indexed citations

12.

Sun, Leina, et al.. (2023). CT‐based radiomics model to predict spread through air space in resectable lung cancer. Cancer Medicine. 12(18). 18755–18766. 6 indexed citations

13.

Yue, Dongsheng, Shidong Xu, Qun Wang, et al.. (2022). Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 40(34). 3912–3917. 37 indexed citations

14.

Zhang, Xuexi, Hao Wang, Wenxu Liu, et al.. (2022). Molecular features and evolutionary trajectory of ASCL1+ and NEUROD1+ SCLC cells. British Journal of Cancer. 128(5). 748–759. 11 indexed citations

15.

Zhang, Bin, Lianmin Zhang, Dongsheng Yue, et al.. (2020). Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis. Translational Lung Cancer Research. 9(4). 1187–1201. 12 indexed citations

16.

Du, Wei, Xing Xu, Qing Niu, et al.. (2017). Spi-B–Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors. Cancer Research. 77(18). 4809–4822. 28 indexed citations

17.

Jia, Bin, Changli Wang, Zhenfa Zhang, & Yanjun Su. (2017). Clinical analysis of single- and multiple-port thoracoscopic lobectomy for lung cancer. Clinical Oncology and Cancer Research. 44(9). 440–443. 1 indexed citations

18.

Yan, Xiaojie, Ding Li, Dan Zhao, et al.. (2017). NUPR1 maintains autolysosomal efflux by activatingSNAP25transcription in cancer cells. Autophagy. 14(4). 654–670. 75 indexed citations

19.

Sun, Bingsheng, et al.. (2016). Significance of interstitial tumor-associated macrophages in the progression of lung adenocarcinoma. Oncology Letters. 12(6). 4467–4476. 6 indexed citations

20.

Wang, Changli, Ran Yang, Dongsheng Yue, & Zhenfa Zhang. (2009). Expression of FAK and PTEN in Bronchioloalveolar Carcinoma and Lung Adenocarcinoma. Lung. 187(2). 104–109. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact